Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Pulmonary Hypertension

Free Subscription 21.08.2023 4 Am J Respir Crit Care Med 1 Ann Am Thorac Soc 1 Arch Cardiol Mex 1 bioRxiv 2 BMC Pulm Med 1 Can J Anaesth 1 Cardiovasc Diagn Ther 2 Chest 1 Circ Res 1 Clin Respir J 1 Clin Transl Sci 1 Commun Biol 1 Comput Biol Med 1 Curr Heart Fail Rep 1 Egypt Heart J 1 Exp Cell Res 1 Gene 1 Int Immunopharmacol 1 Int J Cardiol 1 Int J Mol Sci 2 J Am Coll Cardiol 1 J Vet Intern Med 2 JACC Cardiovasc Imaging 1 Kardiochir Torakochirurgia Pol 3 Lancet Respir Med 1 Life Sci 1 Parasit Vectors 1 Pulm Circ 1 Res Sq 2 Respir Res 1 Semin Respir Crit Care Med 2 Sheng Li Xue Bao 2 Vascul Pharmacol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Respir Crit Care Med

1. HAN MK
   From Conundrum to Cures, Pioneering Breakthroughs in Chronic Obstructive Pulmonary Disease Research: Introduction to an AJRCCM Special Issue.
   Am J Respir Crit Care Med. 2023;208:339-340.
   PubMed        
   
   
2. ROCHESTER CL, Alison JA, Carlin B, Jenkins AR, et al
   Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline.
   Am J Respir Crit Care Med. 2023;208:e7-e26.
   PubMed         Abstract available
   
   
3. BRITTAIN EL, Tedford RJ, Maron BA
   Reply to: Can Pulmonary Arterial Compliance Be a Prognostic Marker for Pulmonary Hypertension?
   Am J Respir Crit Care Med. 2023 Aug 10. doi: 10.1164/rccm.202307-1180.
   PubMed        
   
   
4. WU Y, Su X, Wang J, Zhang H, et al
   Can Pulmonary Arterial Compliance Be a Prognostic Marker for Pulmonary Hypertension?
   Am J Respir Crit Care Med. 2023 Aug 10. doi: 10.1164/rccm.202306-1076.
   PubMed        
   
   

   
   Ann Am Thorac Soc

5. SAHAY S, Lane J, Sharpe MG, Toth D, et al
   Impact on Pulmonary Hypertension Hemodynamic Classification Based on the Methodology Used to Measure Pulmonary Artery Wedge Pressure and Cardiac Output.
   Ann Am Thorac Soc. 2023 Aug 10. doi: 10.1513/AnnalsATS.202303.
   PubMed         Abstract available
   
   

   
   Arch Cardiol Mex

6. ROMERO-ZERTUCHE D, Santos-Martinez LE, Loaiza-Sanchez JF, Moreno-Ruiz LA, et al
   Echocardiographic analysis of pulmonary arterial systolic pressure in pulmonary hypertension.
   Arch Cardiol Mex. 2023;93:267-275.
   PubMed         Abstract available
   
   

   
   bioRxiv

7. FERNANDEZ-GONZALEZ A, Mukhia A, Nadkarni J, Willis GR, et al
   Immunoregulatory macrophages modify local pulmonary immunity and ameliorate hypoxic-pulmonary hypertension.
   bioRxiv. 2023 Aug 2:2023.07.31.551394. doi: 10.1101/2023.07.31.551394.
   PubMed         Abstract available
   
   

   
   BMC Pulm Med

8. JIN Y, Guo G, Wang C, Jiang B, et al
   Association of red cell distribution width with pulmonary arterial hypertension in patients with mixed connective tissue disease.
   BMC Pulm Med. 2023;23:299.
   PubMed         Abstract available
   
   
9. LIAN G, You J, Lin W, Gao G, et al
   Bioinformatics analysis of the immune cell infiltration characteristics and correlation with crucial diagnostic markers in pulmonary arterial hypertension.
   BMC Pulm Med. 2023;23:300.
   PubMed         Abstract available
   
   

   
   Can J Anaesth

10. MARCUS B, Marynen F, Fieuws S, Van Beersel D, et al
    The perioperative use of inhaled prostacyclins in cardiac surgery: a systematic review and meta-analysis.
    Can J Anaesth. 2023 Jun 28. doi: 10.1007/s12630-023-02520.
    PubMed         Abstract available
    
    

    
    Cardiovasc Diagn Ther

11. YUAN C, Zhang Q
    Risk factors for microalbuminuria in adult Tibetan patients with high-altitude pulmonary hypertension: a cross-sectional study.
    Cardiovasc Diagn Ther. 2023;13:336-344.
    PubMed         Abstract available
    
    

    
    Chest

12. MOINZADEH P, Bonella F, Oberste M, Weliwitage J, et al
    Impact of systemic sclerosis-associated interstitial lung disease with and without pulmonary hypertension on survival - a large cohort study of the German network for systemic sclerosis.
    Chest. 2023 Aug 13:S0012-3692(23)05274-1. doi: 10.1016/j.chest.2023.
    PubMed         Abstract available
    
    
13. KULARATNE M, Eyries M, Savale L, Humbert M, et al
    Isolated Pulmonary Arteriovenous Malformations Associated With BMPR2 Pathogenic Variants.
    Chest. 2023;164:e23-e26.
    PubMed         Abstract available
    
    

    
    Circ Res

14. ZHOU X, Jiang Y, Wang Y, Fan L, et al
    Endothelial FIS1 DeSUMOylation Protects Against Hypoxic Pulmonary Hypertension.
    Circ Res. 2023 Aug 17. doi: 10.1161/CIRCRESAHA.122.321200.
    PubMed         Abstract available
    
    

    
    Clin Respir J

15. RAWLINGS GH, Novakova B, Armstrong I, Thompson AR, et al
    A systematic review of psychological interventions in adults with pulmonary hypertension: Is the evidence-base disproportionate to the problem?
    Clin Respir J. 2023 Aug 15. doi: 10.1111/crj.13685.
    PubMed         Abstract available
    
    

    
    Clin Transl Sci

16. YU X, Wu M, Meng Q, Zhu W, et al
    Ligustrazine alleviates pulmonary arterial hypertension in rats by promoting the formation of myocardin transcription complex in the nucleus of pulmonary artery smooth muscle cells.
    Clin Transl Sci. 2023;16:1369-1380.
    PubMed         Abstract available
    
    

    
    Commun Biol

17. JOSE A, Elwing JM, Kawut SM, Pauciulo MW, et al
    Human liver single nuclear RNA sequencing implicates BMPR2, GDF15, arginine, and estrogen in portopulmonary hypertension.
    Commun Biol. 2023;6:826.
    PubMed         Abstract available
    
    

    
    Comput Biol Med

18. LI Y, Fu Y, Liu Y, Zhao D, et al
    An optimized machine learning method for predicting wogonin therapy for the treatment of pulmonary hypertension.
    Comput Biol Med. 2023;164:107293.
    PubMed         Abstract available
    
    

    
    Curr Heart Fail Rep

19. NANDULA PS, Shah SD, Caputo A, Papa S, et al
    Medical Management of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
    Curr Heart Fail Rep. 2023;20:263-270.
    PubMed         Abstract available
    
    

    
    Egypt Heart J

20. PUTRA SD, Prakoso R, Sembiring AA, Sakti DDA, et al
    Palliative interatrial septum stenting with a vascular stent in a chronic thromboembolic pulmonary hypertension patient: Is it beneficial?
    Egypt Heart J. 2023;75:70.
    PubMed         Abstract available
    
    

    
    Exp Cell Res

21. MAIMAITIAILI N, Zeng Y, Ju P, Zhakeer G, et al
    NLRC3 deficiency promotes hypoxia-induced pulmonary hypertension development via IKK/NF-kappaB p65/HIF-1alpha pathway.
    Exp Cell Res. 2023 Aug 14:113755. doi: 10.1016/j.yexcr.2023.113755.
    PubMed         Abstract available
    
    

    
    Gene

22. ZI-YANG Y, Nanshan X, Dongling L, Tao H, et al
    ACE2 gene polymorphisms are associated with elevated pulmonary artery pressure in congenital heart diseases.
    Gene. 2023;882:147642.
    PubMed         Abstract available
    
    

    
    Int Immunopharmacol

23. YUAN J, Li S, Han Y, Li F, et al
    Restoration of miR-328a-5p function curtails hypoxic pulmonary hypertension through a mechanism involving PIN1/GSK3beta/beta-catenin axis.
    Int Immunopharmacol. 2023;123:110599.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

24. PALMIERO G, Monda E, Verrillo F, Dongiglio F, et al
    Prevalence and clinical significance of right ventricular pulmonary arterial uncoupling in cardiac amyloidosis.
    Int J Cardiol. 2023;388:131147.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

25. DURMUS N, Chen WC, Park SH, Marsh LM, et al
    Resistin-like Molecule alpha and Pulmonary Vascular Remodeling: A Multi-Strain Murine Model of Antigen and Urban Ambient Particulate Matter Co-Exposure.
    Int J Mol Sci. 2023;24:11918.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

26. COSTANZO MR, Marwick TH
    Right Atrium as Barometer of Right Ventricular Stiffness and Treatment Responsiveness in Precapillary Pulmonary Hypertension.
    J Am Coll Cardiol. 2023;82:718-720.
    PubMed        
    
    
27. WESSELS JN, van Wezenbeek J, de Rover J, Smal R, et al
    Right Atrial Adaptation to Precapillary Pulmonary Hypertension: Pressure-Volume, Cardiomyocyte, and Histological Analysis.
    J Am Coll Cardiol. 2023;82:704-717.
    PubMed         Abstract available
    
    

    
    J Vet Intern Med

28. YUCHI Y, Suzuki R, Saito T, Yasumura Y, et al
    Echocardiographic characteristics of dogs with pulmonary hypertension secondary to respiratory diseases.
    J Vet Intern Med. 2023 Aug 18. doi: 10.1111/jvim.16836.
    PubMed         Abstract available
    
    

    
    JACC Cardiovasc Imaging

29. ZHONG L, Leng S, Alabed S, Chai P, et al
    Pulmonary Artery Strain Predicts Prognosis in Pulmonary Arterial Hypertension.
    JACC Cardiovasc Imaging. 2023;16:1022-1034.
    PubMed         Abstract available
    
    
30. SANZ J, Nelson KF
    Towards Noninvasive Evaluation of the Right Heart-Pulmonary Circulation Unit.
    JACC Cardiovasc Imaging. 2023;16:1035-1037.
    PubMed        
    
    

    
    Kardiochir Torakochirurgia Pol

31. AMPATZIDOU F, Drosos O, Madesis A, Drossos G, et al
    Pulmonary artery sarcoma presenting as chronic thromboembolic pulmonary hypertension (CTEPH).
    Kardiochir Torakochirurgia Pol. 2023;20:129-131.
    PubMed        
    
    

    
    Lancet Respir Med

32. OLSSON KM, Corte TJ, Kamp JC, Montani D, et al
    Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management.
    Lancet Respir Med. 2023 Aug 14:S2213-2600(23)00259.
    PubMed         Abstract available
    
    
33. DELCROIX M, de Perrot M, Jais X, Jenkins DP, et al
    Chronic thromboembolic pulmonary hypertension: realising the potential of multimodal management.
    Lancet Respir Med. 2023 Aug 14:S2213-2600(23)00292.
    PubMed         Abstract available
    
    
34. NEWMAN J, Pepke-Zaba J
    Illuminating the many faces of pulmonary hypertension.
    Lancet Respir Med. 2023 Aug 14:S2213-2600(23)00291.
    PubMed        
    
    

    
    Life Sci

35. PAHAL P, Sharma S, Braga CL, Santos RT, et al
    Therapeutic effects of hypoxia-preconditioned bone marrow-derived mesenchymal stromal cells and their extracellular vesicles in experimental pulmonary arterial hypertension.
    Life Sci. 2023;329:121988.
    PubMed         Abstract available
    
    

    
    Parasit Vectors

36. COSTA-RODRIGUEZ N, Garcia-Rodriguez SN, Matos JI, Falcon-Cordon Y, et al
    Usefulness of NT-proBNP in dogs with heartworm: could this biomarker be useful to evaluate pulmonary hypertension?
    Parasit Vectors. 2023;16:292.
    PubMed         Abstract available
    
    

    
    Pulm Circ

37. JACOBS S, Payne C, Shaboodien S, Kgatla T, et al
    Gut microbiota crosstalk mechanisms are key in pulmonary hypertension: The involvement of melatonin is instrumental too.
    Pulm Circ. 2023;13:e12277.
    PubMed         Abstract available
    
    

    
    Res Sq

38. KACHABI A, Colebank MJ, Chesler N
    Subject-specific one-dimensional fluid dynamics model of chronic thromboembolic pulmonary hypertension.
    Res Sq. 2023 Aug 3:rs.3.rs-3214385. doi: 10.21203/rs.3.rs-3214385.
    PubMed         Abstract available
    
    

    
    Respir Res

39. KATZ MG, Hadas Y, Vincek A, Freage-Kahn L, et al
    Acid ceramidase gene therapy ameliorates pulmonary arterial hypertension with right heart dysfunction.
    Respir Res. 2023;24:197.
    PubMed         Abstract available
    
    
40. KUANG M, Chen Y, Xing Y, Du M, et al
    Echocardiographic evaluation of right heart failure which might be associated with DNA damage response in SU5416-hypoxia induced pulmonary hypertension rat model.
    Respir Res. 2023;24:202.
    PubMed         Abstract available
    
    

    
    Semin Respir Crit Care Med

41. DELCROIX M, Belge C, Maleux G, Godinas L, et al
    Monographic Issue on Pulmonary Hypertension: Medical and Interventional Treatment for Chronic Thromboembolic Pulmonary Hypertension.
    Semin Respir Crit Care Med. 2023 Aug 11. doi: 10.1055/s-0043-1770122.
    PubMed         Abstract available
    
    

    
    Sheng Li Xue Bao

42. LIU XX, Chen AD, Pan Y, Zhang F, et al
    [Angiotensin-(1-7) improves endothelium-dependent vasodilation in rats with monocrotaline-induced pulmonary arterial hypertension].
    Sheng Li Xue Bao. 2023;75:497-502.
    PubMed         Abstract available
    
    
43. ZHANG S, Tian YN, Song ZY, Wang XT, et al
    [Panax notoginseng saponins improve monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting ADAM10/Notch3 signaling pathway].
    Sheng Li Xue Bao. 2023;75:503-511.
    PubMed         Abstract available
    
    

    
    Vascul Pharmacol

44. CULLEY MK, Rao RJ, Mehta M, Zhao J, et al
    Frataxin deficiency disrupts mitochondrial respiration and pulmonary endothelial cell function.
    Vascul Pharmacol. 2023;151:107181.
    PubMed         Abstract available
    
    
45. ABU-HANNA J, Anastasakis E, Patel JA, Eddama MMR, et al
    Prostacyclin mimetics inhibit DRP1-mediated pro-proliferative mitochondrial fragmentation in pulmonary arterial hypertension.
    Vascul Pharmacol. 2023;151:107194.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: